Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:40 PM
Ignite Modification Date:
2025-12-24 @ 11:40 PM
NCT ID:
NCT00418951
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of AML or high risk MDS undergoing induction chemotherapy or first salvage chemotherapy.
* Age \>/=18 years.
* Patients must sign an informed consent.
Exclusion Criteria:
* Patients with history of anaphylaxis attributed to azole or amphotericin B compounds.
* Patients with clinical or other evidence that indicates that they have proven or probable invasive fungal infection prior to enrollment.
* Patients with total bilirubin levels \> 3 times the upper normal limits (i.e. \> 3.0 mg/dl); or serum glutamic pyruvic transaminase (SGPT)\> 5 times upper limit normal.
* Patients with serum creatinine \> 2.0 mg/dl.
* Patients receiving any medication that is contraindicated with the use of voriconazole.
* Patients who have participated in this study during induction chemotherapy.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00418951
Study Brief:
Protocol Section:
NCT00418951